Bilateral Branch Retinal Vein Occlusion after mRNA-SARS-CoV-2 Booster Dose Vaccination

被引：4

作者：

Gironi, Matteo ^{[1
,2
]}

D'Aloisio, Rossella ^{[2
]}

Verdina, Tommaso ^{[1
]}

Shkurko, Benjamin ^{[3
]}

Toto, Lisa ^{[2
]}

Mastropasqua, Rodolfo ^{[2
]}

机构：

[1] Univ Modena & Reggio Emilia, Ophthalmol Clin, Azienda Osped Univ Modena, Policlin, I-41125 Modena, Italy

[2] Univ G dAnnunzio, Dept Med & Sci Ageing, Ophthalmol Clin, I-66100 Chieti, Italy

[3] Univ Parma, Dept Med & Surg, Ophthalmol Clin, I-43121 Parma, Italy

来源：

JOURNAL OF CLINICAL MEDICINE | 2023年 / 12卷 / 04期

关键词：

COVID; SARS-CoV-2; retinal vein occlusion; RVO; vaccination; branch retinal vein occlusion;

D O I：

10.3390/jcm12041325

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Purpose: We report a case of a patient with a bilateral branch retinal vein occlusion (BRVO) 24 h after a booster vaccination with the mRNA-1237 vaccine. Observations: Fluorescein angiography, performed at three weeks follow-up, showed vascular leakage and blockage, corresponding to hemorrhage areas associated with ischemic areas in the macula and along the arcades involved in the occlusion. Conclusions: The patient was scheduled for urgent injections of intravitreal ranibizumab and laser photocoagulation of the ischemic areas. To the best of our knowledge, this is the first case described of concomitant bilateral RVO after COVID-19 vaccination. The rapid onset of the side effects in a patient with multiple risk factors for thrombotic events suggests that vulnerable microvascular conditions require detailed investigations before administration of a COVID-19 vaccine.

引用

页数：5

共 50 条

[21] Anti-SARS-CoV-2 antibody decay after vaccination and immunogenicity of the booster dose of the BNT162b2 mRNA vaccine in patients with psoriatic arthritis on TNF inhibitors [J].

Venerito, V. ;

Stefanizzi, P. ;

Martinelli, A. ;

Fornaro, M. ;

Galeone, M. G. ;

Tafuri, S. ;

Iannone, F. ;

Lopalco, G. .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (01) :166-169

[22] SARS-CoV-2 antibodies after booster vaccination. Identification of subgroups with poor response [J].

Garcia, B. Ayuso ;

Lema, E. M. Romay ;

Lopez, A. Perez ;

Pinera, A. Suarez ;

Belay, M. C. Pereiro ;

Gonzalez, M. J. Gude ;

Rey, R. Rabunal .

REVISTA CLINICA ESPANOLA, 2023, 223 (06) :379-382

[23] The gut microbiota modifies antibody durability and booster responses after SARS-CoV-2 vaccination [J].

Seong, Hye ;

Yoon, Jin Gu ;

Nham, Eliel ;

Choi, Yu Jung ;

Noh, Ji Yun ;

Cheong, Hee Jin ;

Kim, Woo Joo ;

Kim, Eui Ho ;

Kim, Chulwoo ;

Han, Young-Hee ;

Lim, Sooyeon ;

Song, Joon Young .

JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)

[24] Booster vaccination with SARS-CoV-2 mRNA vaccines and myocarditis in adolescents and young adults: a Nordic cohort study [J].

Hviid, Anders ;

Nieminen, Tuomo A. ;

Pihlstrom, Nicklas ;

Gunnes, Nina ;

Dahl, Jesper ;

Karlstad, Oystein ;

Gulseth, Hanne Lovdal ;

Sundstrom, Anders ;

Husby, Anders ;

Hansen, Jorgen Vinslov ;

Ljung, Rickard ;

Hovi, Petteri .

EUROPEAN HEART JOURNAL, 2024, 45 (15) :1327-1335

[25] PREDICTORS OF REFRACTORY MACULAR EDEMA AFTER BRANCH RETINAL VEIN OCCLUSION FOLLOWING INTRAVITREAL BEVACIZUMAB [J].

Moon, Byung Gil ;

Cho, Ah Ran ;

Kim, You Na ;

Kim, June-Gone .

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (06) :1166-1174

[26] Activation of protein tyrosine phosphorylation after retinal branch vein occlusion in cats [J].

Hayashi, A ;

Imai, K ;

Kim, HC ;

deJuan, E .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (02) :372-380

[27] Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose [J].

Roozen, Geert V. T. ;

Prins, Manon L. M. ;

Prins, Corine ;

Janse, Jacqueline J. ;

Gruyter, Heidi L. M. de ;

Pothast, Cilia R. ;

Huisman, Wesley ;

Koopman, Jan Pieter R. ;

Lamers, Olivia A. C. ;

Kuijer, Marjan ;

Myeni, Sebenzile K. ;

Binnendijk, Rob S. van ;

den Hartog, Gerco ;

Heemskerk, Mirjam H. M. ;

Jochems, Simon P. ;

Feltkamp, Mariet C. W. ;

Kikkert, Marjolein ;

Rosendaal, Frits R. ;

Roestenberg, Meta ;

Visser, Leo G. ;

Roukens, Anna H. E. .

CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (07) :930-936

[28] Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial [J].

Bonelli, Michael ;

Mrak, Daniel ;

Tobudic, Selma ;

Sieghart, Daniela ;

Koblischke, Maximilian ;

Mandl, Peter ;

Kornek, Barbara ;

Simader, Elisabeth ;

Radner, Helga ;

Perkmann, Thomas ;

Haslacher, Helmuth ;

Mayer, Margareta ;

Hofer, Philipp ;

Redlich, Kurt ;

Husar-Memmer, Emma ;

Fritsch-Stork, Ruth ;

Thalhammer, Renate ;

Stiasny, Karin ;

Winkler, Stefan ;

Smolen, Josef S. ;

Aberle, Judith H. ;

Zeitlinger, Markus ;

Heinz, Leonhard X. ;

Aletaha, Daniel .

ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (05) :687-694

[29] Modeling the SARS-CoV-2 Omicron variant dynamics in the United States with booster dose vaccination and waning immunity [J].

Avila-Ponce de Leon, Ugo ;

Perez, Angel G. C. ;

Avila-Vales, Eric .

MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2023, 20 (06) :10909-10953

[30] Severe Aplastic Anemia After Receiving SARS-CoV-2 Moderna mRNA Vaccination [J].

Sridhara, Srilekha ;

Nair, Resmi ;

Stanek, Michael .

JOURNAL OF HEMATOLOGY, 2022, 11 (01) :34-39

← 1 2 3 4 5 →